易瑞沙治疗肺癌致皮肤不良反应的观察与护理
HAINAN MEDICAL JOURNAL（2010）
Abstract
易瑞沙(吉非替尼片)适用于治疗既往接受过化学治疗或不适于化疗的局部晚期或转移性非小细胞肺癌(NSCLC),其作为分子靶向药物已广泛应用于临床.
MoreAI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined